Miller Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Sell
42
-58
-58% -$59.3K 0.01% 54
2026
Q1
$92K Hold
100
0.04% 26
2025
Q4
$107K Hold
100
0.04% 25
2025
Q3
$76.3K Hold
100
0.03% 30
2025
Q2
$78K Hold
100
0.04% 27
2025
Q1
$82.6K Hold
100
0.05% 26
2024
Q4
$77.2K Hold
100
0.04% 26
2024
Q3
$91.7K Hold
100
0.05% 22
2024
Q2
$90.5K Hold
100
0.05% 24
2024
Q1
$77.8K Hold
100
0.05% 27
2023
Q4
$58.3K Hold
100
0.04% 28
2023
Q3
$53.7K Hold
100
0.04% 26
2023
Q2
$46.9K Sell
100
-12
-11% -$5.03K 0.03% 24
2023
Q1
$6K Buy
112
+12
+12% +$4.05K 0.03% 49
2022
Q4
$37K Hold
100
0.03% 31
2022
Q3
$32K Hold
100
0.03% 46
2022
Q2
$32K Hold
100
0.03% 34
2022
Q1
$29K Hold
100
0.02% 38
2021
Q4
$28K Buy
+100
New +$25.4K 0.02% 40

Other funds holding LLY

Miller Wealth Advisors's LLY Position: Q2 2026 in Review

Miller Wealth Advisors reduced its Eli Lilly (LLY) stake by 58% in Q2 2026, selling an estimated $59.3K and leaving 42 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #54.

Miller Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $107K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Miller Wealth Advisors held 42 shares of Eli Lilly worth $21.4K as of Q2 2026.
  • Miller Wealth Advisors sold 58 Eli Lilly shares in Q2 2026, an estimated $59.3K.
  • Eli Lilly made up 0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #54 holding.
  • Miller Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Miller Wealth Advisors's Eli Lilly position peaked at $107K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.